Zydus Lifesciences secures US FDA approval for generic Valbenazine
The company has received final approval to market its generic version of Valbenazine capsules in the US. This drug is used to treat tardive dyskinesia. Production will take place at its Ahmedabad facility.
Subscribe To Our Free Newsletter |